Artificial Intelligence (AI) in Life Sciences Market

The global market for artificial intelligence (AI) in life sciences was $8 billion in 2023. Mass spectrometry technology innovation and biomarker development are helping the market grow, and it is expected to reach $33.5 billion by the end of 2029. The market is forecast to grow at a CAGR of 27.9% from 2024 through 2029.

Key Highlights:

By product, software had the highest share of 65.6% in 2023, and this segment is expected to achieve a CAGR of 30.4% over the forecast period.
By application, the clinical and molecular diagnostics segment had the highest share of 28.9% in 2023. This segment is expected to grow at a CAGR of 27.6% during the forecast period.
By end user, the contract research organization segment had the highest share of 64.5% in 2023. This segment is expected to grow at a CAGR of 29.2% during the forecast period.
In terms of market share, North America was the largest worldwide region in 2023, followed by Europe, Asia-Pacific, and the rest of the world. The North American market is projected to grow at a CAGR of 28.1% over the forecast period.

This report aims to comprehensively study the market size of global artificial intelligence (AI) in the life sciences. Current and historical market revenues can be estimated based on products, applications, end users, and regions.

The Report Includes

26 data tables and 35 additional tables
Analyses of trends in the global market for AI in life sciences, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the current market size and revenue prospects, along with a market share analysis based on product segment, application, end user and region
Facts and figures pertaining to the market dynamics, current and emerging technologies, regulatory scenario and the expected impact of macroeconomic factors
Identification of the AI products and technologies with the highest commercial potential, and their relevant applications in life sciences, specifically precision medicine and personalized healthcare
Overview of ESG developments and sustainability trends, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
Review of patent activity and key patent grants
An analysis of the industry structure, including companies' market shares, merger and acquisition activity, and venture funding outlook
Profiles of the leading companies, including AiCure LLC., Apixio Inc., Atomwise Inc., BenevolentAI and NuMedii Inc.

Chapter 1: Executive Summary

Outlook
Scope of Report
Market Summary

Chapter 2: Market Overview

Artificial Intelligence in Drug Discovery
Intelligence in Molecular Diagnostics
Artificial Intelligence in Clinical Diagnostics
Artificial Intelligence in Clinical Trials
Artificial Intelligence in Precision Medicine

Chapter 3: Market Dynamics

Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Challenges

Chapter 4: Emerging Technologies and Developments

Clinical Trials
Clinical Trials, by Status
Clinical Trials, by Study
Granted Patents

Chapter 5: Market Segmentation Analysis

Market Analysis, by Product
- Global
- Software
- Services
Market Analysis, by Application
- Drug Discovery
- Clinical and Molecular Diagnostics
- Clinical Trials
- Precision and Personalized Medicine
Market Analysis, by End User
- Market Analysis and Forecast
- Contract Research Organizations
- Research Centers and Academic Institutes
- Pharmaceutical and Biotechnology Companies
Market Analysis, by Region
- Global
- North America
- Europe
- Asia-Pacific
- Rest of the World

Chapter 6: Competitive Intelligence

Top Players and Products
Strategic Analysis
Mergers and Acquisitions
Funding

Chapter 7: Appendix

Methodology
Sources
Acronyms
Definitions/Taxonomy

Company Profiles

AiCure
Apixio
Atomwise Inc.
Benevolentai
Enlitic Inc.
Numedii Inc.
Recursion
Zebra Technologies Corp.

List of Tables

Summary Table: Global Market for Artificial Intelligence (AI) in Life Sciences, by Product, Through 2029
Table 1: Publications Referencing Artificial Intelligence in Life Sciences, 2021-2023
Table 2: Artificial Intelligence in Life Science Products from Global Players
Table 3: Different Types of Data Used in the Life Science Industry for Artificial Intelligence
Table 4: Global Regulatory, Ethical Considerations for Artificial Intelligence in Drug Discovery
Table 5: Artificial Intelligence in the Life Sciences: Emerging Technologies
Table 6: Selected Clinical Trial Data for Artificial Intelligence in Life Sciences, 2021-2023
Table 7: Selected Granted Patents of AI in Life Sciences, 2021-2024
Table 8: Global Market for AI in Life Sciences, by Product, Through 2029
Table 9: Global Market for AI in Life Sciences, by Application, Through 2029
Table 10: Global Market for AI in Life Sciences, by End User, Through 2029
Table 11: Global Market for AI in Life Sciences, by Region, Through 2029
Table 12: North American Market for AI in Life Sciences, by Country, Through 2029
Table 13: North American Market for AI in Life Sciences, by Product, Through 2029
Table 14: North American Market for AI in Life Sciences, by Application, Through 2029
Table 15: North American Market for AI in Life Sciences, by End User, Through 2029
Table 16: European Market for AI in Life Sciences, by Country, Through 2029
Table 17: European Market for AI in Life Sciences, by Product, Through 2029
Table 18: European Market for AI in Life Sciences, by Application, Through 2029
Table 19: European Market for AI in Life Sciences, by End User, Through 2029
Table 20: Asia-Pacific Market for AI in Life Sciences, by Country, Through 2029
Table 21: Asia-Pacific Market for AI in Life Sciences, by Product, Through 2029
Table 22: Asia-Pacific Market for AI in Life Sciences, by Application, Through 2029
Table 23: Asia-Pacific Market for AI in Life Sciences, by End User, Through 2029
Table 24: Rest of the World Market for AI in Life Sciences, Through 2029
Table 25: Rest of the World Market for AI in Life Sciences, by Product, Through 2029
Table 26: Rest of the World Market for AI in Life Sciences, by Application, Through 2029
Table 27: Rest of the World Market for AI in Life Sciences, by End User, Through 2029
Table 28: Top Players and Products in Artificial Intelligence (AI) in Life Science Market
Table 29: Mergers and Acquisitions in the Global Market for AI in Life Sciences, 2023-2024
Table 30: Fundings in the Global Market for AI Life Sciences, 2022-2024
Table 31: Report Information Sources
Table 32: Major Acronyms Used in This Report
Table 33: AiCure: Company Snapshot
Table 34: AiCure: Product Portfolio
Table 35: AiCure: News/Key Developments, 2024
Table 36: Apixio: Company Snapshot
Table 37: Apixio: Product Portfolio
Table 38: Apixio: News/Key Developments, 2024
Table 39: Atomwise Inc.: Company Snapshot
Table 40: Atomwise Inc.: Product Portfolio
Table 41: Atomwise Inc.: News/Key Developments, 2022
Table 42: BenevolentAI: Company Snapshot
Table 43: BenevolentAI: Financial Performance, FY 2022 and 2023
Table 44: BenevolentAI: Product Portfolio
Table 45: BenevolentAI: News/Key Developments, 2024
Table 46: Enlitic Inc.: Company Snapshot
Table 47: Enlitic Inc.: Financial Performance, FY 2022 and 2023
Table 48: Enlitic Inc.: Product Portfolio
Table 49: Enlitic Inc.: News/Key Developments, 2024
Table 50: NuMedii Inc.: Company Snapshot
Table 51: NuMedii Inc.: Product Portfolio
Table 52: NuMedii Inc.: News/Key Developments, 2020
Table 53: Recursion: Company Snapshot
Table 54: Recursion: Financial Performance, FY 2022 and 2023
Table 55: Recursion: Product Portfolio
Table 56: Recursion: News/Key Developments, 2023-2024
Table 57: Zebra Technologies Corp.: Company Snapshot
Table 58: Zebra Technologies Corp.: Financial Performance, FY 2022 and 2023
Table 59: Zebra Technologies Corp.: Product Portfolio
Table 60: Zebra Technologies Corp.: News/Key Developments, 2024

List of Figures

Summary Figure: Global Market for Artificial Intelligence (AI) in Life Sciences, by Product, 2021-2029
Figure 1: Breakdown of Publications Referencing Artificial Intelligence in Life Sciences, 2021-2023
Figure 2: Market Dynamics of Artificial Intelligence in Life Sciences
Figure 3: Total Precision Medicine Treatment Spending Worldwide, 2022-2024
Figure 4: Share of Clinical Trials in Global AI in Life Sciences Market, by Status, 2020-2024
Figure 5: Share of Clinical Trials in Global AI in Life Sciences Market, by Study, 2020-2024
Figure 6: Clinical Trials in Global AI in Life Sciences Market, by Interventions, 2020-2024
Figure 7: Patents Granted for AI in Life Sciences Market, by Year, 2020-2023
Figure 8: Global Market Shares of AI in Life Sciences, by Product, 2023
Figure 9: Global Market Shares of AI in Life Sciences, by Application, 2023
Figure 10: Global Market Shares of AI in Life Sciences, by End User, 2023
Figure 11: Global Market Shares of AI in Life Sciences, by Region, 2023
Figure 12: North American Market Shares of AI in Life Sciences, by Country, 2023
Figure 13: North American Market Shares of AI in Life Sciences, by Product, 2023
Figure 14: North American Market Shares of AI in Life Sciences, by Application, 2023
Figure 15: North American Market Shares of AI in Life Sciences, by End User, 2023
Figure 16: European Market Shares of AI in Life Sciences, by Country, 2023
Figure 17: European Market Shares of AI in Life Sciences, by Product, 2023
Figure 18: European Market Shares of AI in Life Sciences, by Application, 2023
Figure 19: European Market Shares of AI in Life Sciences, by End User, 2023
Figure 20: Asia-Pacific Market Shares of AI in Life Sciences, by Country, 2023
Figure 21: Asia-Pacific Market Shares of AI in Life Sciences, by Product, 2023
Figure 22: Asia-Pacific Market Shares of AI in Life Sciences, by Application, 2023
Figure 23: Asia-Pacific Market Shares of AI in Life Sciences, by End User, 2023
Figure 24: Rest of the World Market Shares of AI in Life Sciences, by Product, 2023
Figure 25: Rest of the World Market Shares of AI in Life Sciences, by Application, 2023
Figure 26: Rest of the World Market Shares of AI in Life Sciences, by End User, 2023
Figure 27: BenevolentAI: Revenue Share, by Country/Region, FY 2023
Figure 28: Enlitic Inc.: Revenue Share, by Business Unit, FY 2023
Figure 29: Enlitic Inc.: Revenue Share, by Country/Region, FY 2023
Figure 30: Zebra Technologies Corp.: Revenue Share, by Business Unit, FY 2023

Companies Mentioned

AiCure
Apixio
Atomwise Inc.
Benevolentai
Enlitic Inc.
Numedii Inc.
Recursion
Zebra Technologies Corp.

Table Information

Report Attribute	Details
No. of Pages	100
Published	August 2024
Forecast Period	2024 - 2029
Estimated Market Value ( USD ) in 2024	$ 9.8 Billion
Forecasted Market Value ( USD ) by 2029	$ 33.5 Billion
Compound Annual Growth Rate	27.9%
Regions Covered	Global
No. of Companies Mentioned	8

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4565EUR$4,650USD£3,796GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€5478EUR$5,580USD£4,556GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6574EUR$6,696USD£5,467GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7888EUR$8,035USD£6,560GBP

Key Highlights:

The Report Includes

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Artificial Intelligence in Life Sciences Market Report by Offering, Deployment, Application, and Region 2024-2032

AI In Life Sciences - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

AI in Life Science Analytics Global Market Report 2024

Artificial Intelligence (AI) in Life Sciences Market - Forecasts from 2024 to 2029

AI In Life science Analytics Market Size, Share & Trends Analysis Report By Delivery (Cloud, On-premise), By Component (Software, Hardware, Services), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030